HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $40,000 | +14.3% | 2,000 | 0.0% | 0.02% | +6.2% |
| Q3 2017 | $35,000 | +34.6% | 2,000 | 0.0% | 0.02% | +14.3% |
| Q2 2017 | $26,000 | 0.0% | 2,000 | 0.0% | 0.01% | +7.7% |
| Q1 2017 | $26,000 | +30.0% | 2,000 | 0.0% | 0.01% | +44.4% |
| Q4 2016 | $20,000 | -16.7% | 2,000 | 0.0% | 0.01% | -47.1% |
| Q3 2016 | $24,000 | +26.3% | 2,000 | 0.0% | 0.02% | +21.4% |
| Q2 2016 | $19,000 | -5.0% | 2,000 | 0.0% | 0.01% | -6.7% |
| Q1 2016 | $20,000 | -42.9% | 2,000 | 0.0% | 0.02% | -40.0% |
| Q4 2015 | $35,000 | +25.0% | 2,000 | 0.0% | 0.02% | +13.6% |
| Q3 2015 | $28,000 | -37.8% | 2,000 | 0.0% | 0.02% | -35.3% |
| Q2 2015 | $45,000 | +55.2% | 2,000 | 0.0% | 0.03% | +54.5% |
| Q1 2015 | $29,000 | +52.6% | 2,000 | 0.0% | 0.02% | +15.8% |
| Q4 2014 | $19,000 | – | 2,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 7,048,282 | $126,799,000 | 27.23% |
| First Light Asset Management, LLC | 1,630,591 | $29,334,000 | 5.01% |
| SNYDER CAPITAL MANAGEMENT L P | 3,393,057 | $61,041,000 | 3.48% |
| Bellevue Group AG | 7,663,956 | $137,874,000 | 2.67% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 307,633 | $5,531,000 | 2.52% |
| Lombard Odier Asset Management (Switzerland) SA | 900,000 | $16,191,000 | 2.17% |
| Elk Creek Partners, LLC | 654,362 | $11,772,000 | 2.02% |
| DOHENY ASSET MANAGEMENT /CA | 127,110 | $2,254,000 | 1.79% |
| Granite Investment Partners, LLC | 1,277,438 | $22,981,000 | 1.49% |
| Amia Capital LLP | 69,409 | $1,249,000 | 1.11% |